Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Lt.../ US8816242098 /
TEVA
|
2024-04-22 10:10:00 PM
|
Chg.
+0.02
|
Volume |
Bid3:05:13 PM |
Ask3:05:13 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
12.88USD
|
+0.16%
|
7.95 mill.
Turnover: 85.8 mill. |
12.74Bid Size: 1,000 |
13.00Ask Size: 100 |
14.44 bill.USD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.50 USD |
-76.42% |
| EPS Diluted: |
-0.50 USD |
-76.42% |
| Revenues per Share: |
14.13 USD |
5.21% |
| Book Value per Share: |
7.25 USD |
-7.35% |
| Cash Flow per Share: |
1.22 USD |
-14.74% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
15,846.00 USD |
6.17% |
| Net Income: |
-559.00 USD |
-76.24% |
| Operating Cash Flow: |
1,368.00 USD |
- |
| Cash and Cash Equivalents: |
3,226.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
0.91 |
0.74 |
| P/BV ratio: |
1.78 |
1.44 |
| P/CF Ratio: |
10.56 |
8.56 |
| PEG: |
0.34 |
- |
| Earnings Yield: |
-3.88% |
-4.79% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
14.44 bill. USD |
11.7 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
1.12 bill. |
|
Profitability
| Gross Profit Margin: |
48.25% |
| EBIT Margin: |
2.73% |
| Net Profit Margin: |
-3.53% |
| Return on Equity: |
-6.88% |
| Return on Assets: |
-1.29% |
Financial Strength
| Liquidity I / Cash Ratio: |
26.34% |
| Liquidity II / Quick Ratio: |
54.17% |
| Liquidity III / Current Ratio: |
101.94% |
| Debt / Equity Ratio: |
435.06% |
| Dynam. Debt / Equity Ratio: |
2,584.28% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
